Staphylococcus aureus is a major cause of skin and soft tissue infections and aggravator of the inflammatory skin disease atopic dermatitis (AD). Langerhans cells (LCs) initiate a Th17 response upon exposure to S. aureus, which contributes to host defense but also to AD pathogenesis. However, the molecular mechanisms underlying the unique pro-inflammatory capacities of S. aureus remain unclear. We demonstrate that human LCs directly interact with S. aureus through the pattern-recognition receptor langerin (CD207), which specifically recognizes the conserved β-N-acetylglucosamine (GlcNAc) modifications of wall teichoic acid (WTA) that are not expressed by other staphylococcal species. The WTA glycoprofile strongly influences the production of Th1-and Th17-polarizing cytokines by LCs. Specifically, β-GlcNAc activates LCs, whereas co-decoration of WTA with α-GlcNAc through the enzyme TarM, uniformly present in the AD-associated CC1 lineage, attenuates LC immune activation. Our findings provide important mechanistic insights into the role of S. aureus in inflammatory skin disease.
Introduction
Staphylococus aureus is a common colonizer of the skin and nasal cavities but is also a major cause of skin disease. S. aureus-associated skin and soft tissue infections (SSTIs) are an important cause of disease and hospitalization and account for over 10 million cases each year in the US alone (Hersh et al., 2008) . S. aureus is also an aggravator of the inflammatory skin disease atopic dermatitis (AD, eczema), which affects up to 20% of children and 3% of adults worldwide (Nutten, 2015) . AD-affected skin is characterized by a disturbed composition of the microbiota with low species diversity and dominance of S. aureus (Totte et al., 2016) . In particular, S. aureus strains of the CC1 lineage are overrepresented in AD isolates and were proposed to have particular yet-unidentified features that enable colonization of AD skin (Geoghegan et al., 2017) .
When the skin barrier is breached by pathogens such as S. aureus a coordinated immune response is initiated. This response involves both resident and recruited immune cells as well as secreted antimicrobial factors. Important resident immune cells of the skin epidermis are Langerhans cells (LCs) . These cells fulfill a gatekeeping function by sensing evolutionary conserved pathogen-associated molecular patterns (PAMPs) on invading pathogens through pattern recognition receptors (PRRs). In response, LCs can phagocytose invaders and initiate adaptive immune responses by activating skin-resident immune memory cells or naïve immune cells in the lymph nodes (Kissenpfennig et al., 2005 , Seneschal et al., 2012 .
LCs are equipped with a diverse set of PRRs, including the LC-specific C-type lectin receptor (CLR) langerin (CD207) (Valladeau et al., 2000) .
Wall teichoic acid (WTA) is an evolutionarily conserved and dominant component of the S. aureus cell wall. It plays an important role in nasal colonization, S. aureus-induced endocarditis, beta-lactam resistance and phage-mediated horizontal gene transfer , Weidenmaier et al., 2005 , Brown et al., 2012 , Xia et al., 2011 , Winstel et al., 2013 . In the majority of S. aureus lineages, WTA is composed of a glycopolymer backbone of 20 -40 ribitol-phosphate (RboP) subunits modified by N-acetylglucosamine (GlcNAc) and D-alanine residues. The GlcNAc modifications can be either α-O-linked or β-O-linked to the anomeric C4 of the RboP subunits by the glycosyltransferases TarM and TarS, respectively (Xia et al., 2010 , Brown et al., 2012 . Overall, several S. aureus WTA glycoprofiles can be discriminated: WTA β-GlcNAcylation is conserved in almost all S. aureus strains, whereas WTA α-GlcNAcylation is only present in about one third of the S. aureus isolates, and a small selection of isolates have no WTA glycosylation at all (Li et al., 2015 . In addition, WTA of S. aureus lineage ST395 is composed of a glycerol-phosphate (GroP) backbone modified by N-acetylgalactosamine (GalNAc) instead of the common RboPGlcNAc WTA (Winstel et al., 2013) .
WTA glycosylation is an important determinant in host-pathogen interactions through both innate and adaptive immune recognition. For example, opsonizing antibodies interact with WTA GlcNAc to initiate complement deposition and subsequent phagocytic uptake of S.
aureus (Kurokawa et al., 2013) . Innate immune component interacting with WTA include the scavenger receptor SREC-1, which is important for attachment of S. aureus to the nasal epithelium, and mannose-binding lectin, which initiates deposition of complement C4 on S.
aureus (Baur et al., 2014 , Park et al., 2010 . The interactions with these innate receptors are not influenced by the anomeric configuration of WTA GlcNAc.
S. aureus can enter the epidermis through a damaged stratum corneum, which is an important predisposing determinant for AD (Nakatsuji et al., 2016) . Epicutaneous exposure of LCs to S. aureus initiates Th17 responses, which contribute to host defense but also to AD pathogenesis (Igyártó et al., 2011 , Kobayashi et al., 2015 . Previous studies indeed show that S. aureus-exposed LCs induce T cell proliferation (van der Aar et al., 2013) . However, the molecular interaction between LCs and S. aureus and the functional consequences have received little attention. Therefore, the aim of this study was to investigate the interaction between S. aureus and human LCs at a molecular and functional level.
We demonstrate an important role of the PRR langerin in sensing the S. aureus cell wall component WTA. Langerin specifically recognizes β-GlcNAc modifications on S. aureus WTA, which contributes to LC activation and production of Th1-and Th17-polarizing cytokines. The selectivity of langerin for β-GlcNAc also explains the lack of binding to other non-AD associated staphylococcal species. Interestingly, simultaneous decoration of WTA with α-GlcNAc impairs langerin interaction and attenuates the functional response of LCs, implying that S. aureus can modulate immune detection and subsequent inflammation in the epidermis. In conclusion, we identify WTA as a pathogen-associated molecular pattern of S. aureus, which is recognized by langerin on LCs.
Results

Langerin is a receptor for S. aureus on human LCs
To determine whether LCs and S. aureus interact directly, we incubated primary LCs isolated from human skin with GFP-expressing S. aureus. LCs from four different donors bound S. aureus in a dose-dependent manner ( Figure 1A) . The levels at which the interaction was saturated varied between the donors from approximately 40% (donor 1) to 80% (donor 3) of S. aureus-positive LCs. To investigate the nature of interacting receptors on LCs, we preincubated LCs with mannan, a ligand for many CLRs. Depending on the bacteria-to-cell ratio, S. aureus binding was reduced by 35-70% compared to non-blocking conditions in all donors ( Figure 1A) . Similarly, the interaction was inhibited by approximately 35% by pre-incubation of the LCs with the monosaccharide GlcNAc. As langerin is a mannan-and GlcNAc-specific CLR that is exclusively expressed on LCs, we investigated whether langerin would be involved in interaction with S. aureus. Indeed, pre-incubation with an anti-langerin blocking antibody reduced binding of (spa and sbi-deficient) S. aureus in donors 3 and 4 by 25-50% compared to control, depending on the infective dose ( Figure 1A ). To confirm involvement of langerin in the interaction between S. aureus and LCs, we introduced langerin in THP1 cells.
Transduction of langerin, but not of empty vector (EV), conferred S. aureus binding to THP-1 cells, which could be completely inhibited by addition of mannan or anti-langerin blocking antibody ( Figure 1B) . Although it was previously demonstrated that S. aureus-exposed LCs initiate T cell proliferation (van der Aar et al., 2013) , the functional response of LCs was not assessed. Therefore, we incubated MUTZ-3-derived LCs (muLCs), a well-established cell model for human LCs (Masterson et al., 2002 , Santegoets et al., 2006 , with S. aureus and measured muLC activation through expression of co-stimulatory molecules and cytokine production after 24 hours. Indeed, muLCs upregulated expression of co-stimulatory molecules CD80 and CD86 and produced significant amounts of IL-8 and IL-12p70 in a dose-dependent response to S. aureus ( Figure 1C ). Together, these data demonstrate that LCs respond to S. aureus and that langerin is an important innate receptor for S. aureus on human LCs.
Langerin recognizes S. aureus in a tarS-dependent manner through the conserved
WTA β-GlcNAc epitope
To further investigate langerin interaction with staphylococci, we tested binding of a FITClabeled trimeric construct of the extracellular domain of human langerin (langerin-FITC) to a broader collection of S. aureus strains (18 strains from 11 different clonal complexes (CCs)) as well as several coagulase-negative staphylococci (CoNS) (Figure 2A ). Langerin-FITC bound to 16 out of 18 (89%) tested S. aureus strains but to none of the tested CoNS species, indicating that langerin interacts with a ligand that is specific for and highly conserved in S.
aureus. The three tested S. aureus strains that showed no or low-level binding of langerin-FITC (ED133, Lowenstein and PS187; Figure 2A) , differ from the other tested S. aureus strains in the structural composition of WTA. ED133 and Lowenstein completely lack WTA GlcNAcylation, whereas PS187 belongs to the ST395 lineage that expresses GroP-GalNAc WTA (Li et al., 2015 , Lee et al., 2015 , Winstel et al., 2013 . Given the high density of WTA on the S. aureus surface and apparent correlation between langerin interaction and WTA structure, we hypothesized that WTA GlcNAc modifications are likely candidates for the interaction with langerin.
To test this, we assessed binding of langerin-FITC to a panel of S. aureus knockout strains, which lack glycosyltransferases TarM and TarS required to modify WTA with α-GlcNAc and β-GlcNAc, respectively. Loss of both glycosyltransferases (ΔtarMS) reduced langerin-FITC binding to S. aureus to background levels (Figures 2B and S1BC), demonstrating that WTA GlcNAc is the target for langerin. To investigate whether langerin specifically recognized either α-GlcNAc or β-GlcNAc, we tested the individual TarM and TarS knockout strains as well as ΔtarMS complemented with either tarM or tarS on an expression plasmid (ΔtarMS ptarM and ΔtarMS ptarS). Langerin-FITC only bound to S. aureus strains that express β-GlcNAc, whereas α-GlcNAc was dispensable for binding (Figures 2B and S1BC) . Similarly, langerin-FITC binding to S. aureus strains 82086 and PS66, which are naturally deficient for WTA α-GlcNAc, was completely abrogated in isogenic ΔtarS strains ( Figure 2C ). These Since S. aureus expresses many human-specific factors (Koymans et al., 2016) , we also investigated the interaction with murine langerin-FITC, which has 76% identity with the human langerin-FITC construct (Hanske et al., 2017) . Binding of murine langerin-FITC to S. aureus was detectable, however binding levels were 10 to 100-fold lower than human langerin ( Figure S1A ), suggesting the langerin-S. aureus interaction displays a certain degree of species-specificity.
Altogether, these data show that human langerin interacts with S. aureus in a tarSdependent manner through the conserved β-GlcNAc WTA modification and that the level of interaction is influenced by the simultaneous modification with α-GlcNAc.
S. aureus-induced production of Th1/Th17 polarizing cytokines by LCs is influenced by the WTA glycoprofile
Given the importance of langerin for interaction between S. aureus and LCs, we investigated whether distinct WTA GlcNAc glycoprofiles influenced the LC response at the level of costimulatory molecules and cytokine expression. Stimulation of muLCs for 24h with γ-irradiated wildtype S. aureus (WT) induced upregulation of activation markers CD80, CD83
and CD86 ( Figure 3A) . Stimulation with β-GlcNAc deficient S. aureus (ΔtarS) reduced expression of these markers compared to WT, whereas stimulation with α-GlcNAc deficient S. aureus (ΔtarM) enhanced expression. MuLCs secreted significant levels of IL-6, IL-8 IL-12p70, IL-23p19 and TNFα ( Figure 3B ), but not anti-inflammatory cytokine IL-10 (not shown), in response to S. aureus. Especially IL-8, IL-12p70 and IL-23p19 were highly produced.
Similar to the activation markers, stimulation of muLCs with S. aureus ΔtarS reduced IL-6, IL-8, IL-12p70, IL-23p19 and TNFα secretion compared to WT, whereas stimulation with S.
aureus ΔtarM significantly enhanced secretion of these cytokines ( Figure 3B) . Interestingly, the level of activation matched the interaction levels of recombinant langerin-FITC to S. aureus WT, ΔtarM and ΔtarS strains ( Figure 2B ). These data suggest that the previously described Th17-polarizing response initiated by LCs in response to S. aureus is strongly influenced by detection of WTA β-GlcNAc. Moreover, the presence of WTA α-GlcNAc attenuates the LC response to S. aureus.
Discussion
Despite the emerging role of LCs in S. aureus-mediated skin inflammation, the molecular interaction between LCs and S. aureus has not been clarified. We identify WTA as a PAMP of S. aureus, of which the β-GlcNAc modifications are recognized by langerin on LCs. This interaction contributes to LC activation and production of Th1-and Th17-polarizing cytokines.
Importantly, the extend of LC activation is strongly influenced by the WTA glycoprofile and suggest the possibility for immune evasion. Although several innate receptors have been described for S. aureus WTA, langerin is the first human innate receptor to discriminate between the α-GlcNAc and β-GlcNAc modifications.
Similar to lipopolysaccharide (LPS) of Gram-negative bacteria, WTA is an abundant evolutionarily conserved feature on the surface of Gram-positive bacteria and essential for maintenance of cell wall architecture and bacterial physiology. Therefore, it is advantageous for the host to recognize such structures in a timely manner through PRRs that are strategically localized at mucosal surfaces. In the case of S. aureus, a common colonizer of skin but also a major cause of skin disease, recognition of S. aureus WTA by langerin on epidermal LCs could be key to maintaining skin homeostasis. Since bacterial physiology is severely affected without WTA (Weidenmaier and Lee, 2016) , bacteria have evolved other ways to regulate WTA expression and composition. First of all, WTA density depends on expression of tarH, which encodes the energy generating component of the WTA ABC transporter TarGH. Importantly, the amount of WTA correlates to the ability of S. aureus to induce skin abscess formation (Wanner et al., 2017) . Second, studies on lytic podophage infection of S. aureus suggest careful regulation of WTA GlcNAcylation (Li et al., 2015) . In support of this, in silico genome analysis identified tarM as part of the GraRS regulon (Falord et al., 2011) , which is known to control resistance to cationic antimicrobials, oxidative stress and growth at high temperatures. Whether and how conditions during skin colonization affect WTA density or GlcNAcylation remains to be determined and will require the development of analytical tools that can accurately and immediately analyze the WTA glycoprofile.
We show that LCs respond to S. aureus with production of a Th1/Th17-polarizing cytokine profile. These data corroborate finding by others, who have demonstrated that LCs internalize S. aureus and subsequently polarize T cells towards Th17 (Igyártó et al., 2011 , Kobayashi et al., 2015 , van der Aar et al., 2013 , Iwamoto et al., 2017 . We now elucidate that detection of S. aureus WTA β-GlcNAc is of critical importance for the induced response. LCs and langerin were previously implicated in host defense against various other pathogens.
LCs internalize and break down HIV-1 viral particles in a langerin-dependent manner to prevent infection of deeper layers of the mucosa (de Witte et al., 2007 , Ribeiro et al., 2016 .
Langerin has also been identified as a major receptor for fungal pathogens on LCs through recognition of mannose and beta-glucan structures (de Jong et al., 2010) . The Gramnegative bacterium Yersinia pestis is the only other bacterium known to interact with langerin through its LPS core oligosaccharide (Yang et al., 2015) . We hereby identify S. aureus as a new langerin-interacting pathogen.
As is the case for many S. aureus virulence factors, we observe a certain degree of species specificity for the interaction between langerin and WTA (Koymans et al., 2016) . Despite the high homology between human and mouse langerin (66% identity), the binding levels of mouse langerin were approximately 50-fold lower compared to human langerin. This corroborates previous studies that reported differences in ligand specificity of these orthologs (Hanske et al., 2017) . It has become increasingly clear that mouse and human skin immunology can be very different, varying from altered receptor specificities to unique cell types and associated functions. This limits the translation of data obtained from mouse studies to humans. The different ligand specificities and thereby S. aureus WTA binding potential of human and mouse langerin are yet another example of this.
S. aureus is a driver of AD disease progression, which is mediated by LCs (Kobayashi et al., 2015) . Interestingly, CD207, the gene encoding for langerin, was identified in genome-wide association studies as an AD susceptibility locus (Paternoster et al., 2015 , Cai et al., 2017 .
Curiously, polymorphisms in a putative enhancer region of CD207, which are suggested to enhance expression of langerin, were protective for AD. Our data now functionally link langerin to S. aureus. One might hypothesize that enhanced langerin expression results in enhanced bacterial recognition, which helps to eradicate S. aureus and prevents the development of chronic inflammation as observed in AD. However, an alternative explanation could be that S. aureus exploits langerin interaction to intentionally elicit inflammation to perturb the skin barrier and release nutrients. Since S. aureus is largely resistant to host defenses but most of the other commensals are not, this could explain the strong association between S. aureus and AD and the described driver function of S. aureus in AD disease progression. This suggests that langerin could play an important role in sensing and regulating skin microbiota homeostasis.
Although S. aureus is associated with AD in general, the CC1 lineage is overrepresented in isolates from AD skin (Geoghegan et al., 2017) . This lineage was suggested to have particular yet-unidentified features that enable colonization of and proliferation in AD skin.
Interestingly, all CC1 strains are tarM-positive (Winstel et al., 2014) . Therefore, CC1 strains have the potential to regulate their WTA glycoprofile, balancing the inflammatory status of the skin and gaining an advantage to colonize AD skin. Therefore, our data provide molecular insight into the association between AD and S. aureus from two different angles: on the immunological side we show how langerin and LCs are involved in the immune response to S. aureus, while on the microbiological side the involvement of langerin could explain the association of S. aureus but not CoNS species with AD, and possibly also the overrepresentation of tarM-bearing CC1 strains in AD.
In conclusion, we identify WTA as a PAMP on S. aureus and pinpoint langerin as a molecular 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Ethics statement
Human skin tissue was collected from otherwise healthy donors undergoing corrective breast or abdominal surgery. This study, including the tissue harvesting procedures, were approved by the Medical Ethics Review Committee of the Academic Medical Center.
Bacterial culture
S. aureus, S. capitis, S. carnosus, S. epidermidis, S. lugdunensis, S. pseudintermedius, S.
saprophyticus and S. simulans strains were grown overnight at 37°C with agitation in 5 ml Todd-Hewitt broth (THB; Oxoid). For S. aureus strains that were plasmid complemented THB was supplemented with 10 µg/ml chloramphenicol (Sigma Aldrich). A fresh 5 ml THB culture was inoculated by 150 µl overnight culture and grown to an optical density at 600 nm (OD 600nm ) of 0.4 for S. capitis and to OD 600nm 0.6-0.7 for all other bacteria, which corresponds to mid-exponential growth phase.
Cell culture and differentiation
MUTZ-3 cells (human, male; ACC-295, DSMZ) were cultured in a 12-well tissue culture plates (Corning) at a density of 0.5-1.0x10 6 cells/ml in MEM-alpha (Gibco) with 20% fetal bovine serum (FBS, Hyclone, GE Healthcare), 1% GlutaMAX (Gibco), 10% conditioned supernatant from renal carcinoma cell line 5637 (ACC-35, DSMZ), 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco) at 37°C with 5% CO 2 . We obtained MUTZ-3 derived Langerhans cells (muLCs) by differentiation of MUTZ-3 cells for 10 days in 100 ng/ml
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF, GenWay Biotech), 10 ng/ml
Transforming Growth Factor-beta (TGFβ; R&D Systems) and 2.5 ng/ml Tumor Necrosis Factor-alpha (TNFα; R&D Systems) as described previously (Masterson et al., 2002 , Santegoets et al., 2006 . The phenotype of differentiated muLCs was verified by surface staining of CD34 (clone 581, BD Biosciences), CD1a (clone HI149, BD Biosciences) and CD207 (clone DCGM4, Beckman Coulter) using the respective antibodies and analysis by flow cytometry (FACSVerse, BD Biosciences). Data were analyzed using FlowJo 10 (FlowJo, LLC).
THP1 cells (human, male; TIB-202, ATCC) transduced with a lentiviral langerin construct or empty vector (EV) were cultured in RPMI (Lonza) supplemented with 5% FBS (Biowest), 1%
GlutaMAX 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco) at 37°C with 5% CO 2 .
METHOD DETAILS
Isolation of primary human Langerhans cells
Human Langerhans cells were isolated as described previously (Ribeiro et al., 2016) . In short, skin grafts were obtained using a dermatome (Zimmer) and incubated in medium supplemented with Dispase II (1 U/ml, Roche Diagnostics) after which epidermal sheets were separated from the dermis and cultured for three days. After incubation, migrated LCs were harvested and further purified using a Ficoll gradient (Axis-shield). Isolated LCs were routinely 90% pure (CD1a+ Langerin+) and were frozen in Iscoves Modified Dulbeccos's Medium (IMDM, Thermo Fischer Scientific) supplemented with 20% FBS and 10% DMSO.
Before use, LCs were thawed by drop-wise addition of cold IMDM with 10% FBS, washed twice and incubated in IMDM with FBS for 2 hours at 37°C with 5% CO 2 to recover.
Creation of GFP-expression S. aureus
To create GFP-expressing bacteria, S. aureus Newman wildtype and S. aureus Newman ΔspaΔsbi were transformed as described previously with pCM29, which encodes superfolded green fluorescent protein (sGFP) driven by the sarAP1 promoter (Pang et al., 2010, Schenk and Laddaga, 1992) . In short, competent S. aureus were electroporated with pCM29 isolated from E. coli DC10B with a Gene Pulser II (BioRad; 100 Ohm, 25uF, 2.5kV).
After recovery, bacteria were selected on TH agar supplemented with 10 µg/ml chloramphenicol. A single colony was grown in THB with 10 µg/ml chloramphenicol under the usual growth conditions. Bacterial expression of GFP was verified by confocal laser scanning microscopy (Leica SP5, Leica).
Gamma-irradiation of S. aureus
Gamma-irradiated stocks of S. aureus strains were made by harvesting cultures in midexponential growth phase by centrifugation (4,000 rpm, 8 min), which were concentrated 10x in phosphate-buffered saline (PBS; Lonza) with 17% glycerol (VWR), frozen at -70°C and exposed to 10 kGy of γ-radiation (Synergy Health, Ede, The Netherlands). Loss of viability of S. aureus was verified by plating of the irradiated bacteria. A non-irradiated aliquot that underwent the same freezing procedure was used to determine the concentration of colony forming units (CFU) of the irradiated stocks.
Lentiviral transduction
A TrueORF sequence-validated cDNA clone of human CD207 (OriGene Technologies) was amplified by PCR using Phusion polymerase (Thermo Fisher) and primers hLangerin-Fw and hLangerin-FLAG-Rv (IDT). The PCR amplicon was cloned in a BIC-PGK-Zeo-T2a-mAmetrine;EF1A construct by Gibson assembly (NEB) according to the manufacturer's instructions. The langerin-encoding vector and an empty vector (EV) control were introduced into THP1 cells by lentiviral transduction, as described by Van de Weijer et al. (van de Weijer et al., 2016) . In short, lentivirus was produced by HEK293T cells (CRL-3216, ATCC) in 24-well plates using standard lentiviral production protocols and third-generation packaging vectors. After 3-4 days the supernatant containing the viral particles was harvested and stored at -70ºC to kill any remaining cells. Approximately 50,000 THP1 cells were transduced by spin infection (1000xg, 2 h, 33°C) using 100 µl supernatant supplemented with 8 µg/ml polybrene (Santa Cruz Biotechnology). Complete medium was added after centrifugation and cells were selected three days post-infection by 100 µg/ml zeocin (Gibco).
saline (pH 7.2) containing 20 mM D-mannose (Sigma Aldrich) and 5 mM CaCl 2 . After stirring for 90 min at room temperature, the reaction was quenched by addition of 50 mM ethanolamine (pH 8.5, Sigma Aldrich). Unreacted dye molecules were removed by buffer exchange using a Zeba spin column (Thermo Fisher) and active protein was purified over mannan affinity column as described above. All chemicals used for the production of recombinant langerin extracellular domains were obtained from Carl Roth if not indicated otherwise.
Langerin binding assay
Bacteria in mid-exponential growth phase were harvested by centrifugation (4,000 rpm, 8 minutes) and resuspended at OD 600nm 0.4 in TSM buffer with 0.1% BSA. Bacteria were incubated with 1-50 µg/ml recombinant langerin-FITC (human or mouse) for 30 minutes at 37°C with agitation, washed once with TSM 1% BSA, fixed in 1% formaldehyde and analyzed by flow cytometry. We determined langerin-FITC binding of the bacteria using the geometric mean signal in the FITC channel.
muLC stimulation
We stimulated 5x10 4 muLCs with S. aureus USA300 WT, USA300 ΔtarM or USA300 ΔtarS at bacteria-to-cell ratios of 0, 1, 10 and 50 in IMDM with 10% FBS. After 24 hours, supernatants were collected by centrifugation (300xg, 10 min, 4°C) and stored at -150°C until further analysis, and cells were washed once in PBS 0.1% BSA. Expression levels of the activation and maturation markers CD80, CD83 and CD86 were determined by flow cytometry using antibody clones 2D10 (CD80), HB15e (CD83) and IT2.2 (CD86) (Sony Biotechnology) and their corresponding isotype controls (BD Biosciences).
Cytokine assays
The IL-8 and IL12p70 concentrations were initially determined by ELISA (Sanquin and Thermo Fisher, respectively) according to the manufacturer's instructions. Concentrations of IL-6, IL-8, IL-10, IL-12p70, IL-23p19 and TNFα were determined by Luminex xMAP assay (Luminex Corporation), performed by Multiplex Core Facility UMC Utrecht, The Netherlands.
QUANTIFICATION AND STATISTICAL ANALYSIS
We analyzed flow cytometry data using FlowJo 10 (FlowJo LLC). Statistical analyses were performed using Graphpad Prism 7.02 (GraphPad Software). We used unpaired two-tailed ttests for comparisons between two groups and one-way ANOVAs with a common control group followed by Dunnett's test for comparisons between multiple groups. The human and mouse langerin concentration curves were tested using a two-way ANOVA followed by Tukey's test for multiple comparisons. Differences were considered significant at p ≤ 0.05. 
